{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04543",
      "entity_text" : "Fraxetin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Fraxetin inhibited osteoclast differentiation and function through the suppression of p38 signaling and subsequently, the suppression of osteoclast specific gene expression, including tartrate resistant acid phosphatase, nuclear factor of activated T-cells, cytoplasmic 1, and cathepsin K.",
  "reading_complete" : "2020-08-03T17:37:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:36:57Z",
  "trigger" : "inhibited",
  "evidence" : [ "Fraxetin inhibited osteoclast differentiation" ],
  "pmc_id" : "6089765",
  "score" : 0
}